✦ LIBER ✦

Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution Experience

✍ Scribed by Voss, Martin H.; Lunning, Matthew A.; Maragulia, Jocelyn C.; Papadopoulos, Esperanza B.; Goldberg, Jenna; Zelenetz, Andrew D.; Horwitz, Steven M.

Book ID: 123510747
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 374 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Dose Chemotherapy and Autologous He

High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation Early during the Course of Disease Appears to Improve Outcomes of Patients T Cell Non-Hodgkin Lymphoma: Results of a Single-Institution Experience

✍ Ayala, Ernesto; Tomblyn, Marcie R.; Kharfan-Dabaja, Mohamed; Locke, Frederick; N 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Long-term remission in a patient with he

Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation

✍ Zaher K. Otrock; Hassan A. Hatoum; Ziad M. Salem; Ayman Tawil; Rami A. Mahfouz; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB

High-dose chemotherapy using BEAM for tu

High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma

✍ Buser, A S; Heim, D; Bucher, C; Tichelli, A; Gratwohl, A; Passweg, J R 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views